Screening and Brief Intervention for Drug Diversion

Age: 18+

Sex: Any

Trial Phase: Phase 1

Sponsor: California State University, Long Beach

Disqualifiers: Immediate mental health services

Compensation: Varies

Number of Visits: 3

120 Participants Needed

Trial Summary

What is the purpose of this trial?

A pilot randomized controlled trial to assess the feasibility, acceptability, and impact of screening and brief intervention to address prescription stimulant misuse and diversion among college students.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the Screening and Brief Intervention for Drug Diversion generally safe for humans?

The research articles provided do not contain specific safety data for the Screening and Brief Intervention for Drug Diversion or eSBI. They focus on issues related to drug diversion, such as misuse and illegal distribution, rather than the safety of the intervention itself. ^{1 2 3 4 5}

How is the eSBI treatment different from other treatments for drug diversion?

The eSBI treatment is unique because it uses a brief intervention approach, which is a short, focused conversation aimed at encouraging individuals to change their drug use behavior. Unlike traditional treatments that may involve long-term therapy or medication, eSBI is designed to be quick and can be integrated into various settings like schools or emergency departments, making it more accessible and potentially reaching individuals who are not actively seeking treatment. ^{6 7 8 9 10}

Eligibility Criteria

This trial is for college students aged 18+ who have a history of prescription stimulant misuse or diversion in the past three months, or those scheduled for a physical/wellness exam at the campus where the intervention takes place. Students needing urgent mental health services during the study will be excluded.

Inclusion Criteria

Active recruitment: Student has a past 3 month history of PSM or PSD

I have an upcoming physical or wellness exam scheduled.

I am 18 or older and a student at the intervention site.

Exclusion Criteria

Any eligible student who, during the course of the session, demonstrates the need for immediate mental health services, will have the study session terminated so that participant can receive needed care.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive either a face-to-face or e-intervention focused on prevention or brief intervention for prescription stimulant misuse and diversion

4 weeks

1 visit (in-person) for F2F group, 1 session (virtual) for eSBI group

Follow-up

Participants are monitored for changes in prescription stimulant misuse and diversion behaviors

4 weeks

2 assessments (virtual)

Treatment Details

Interventions

• eSBI

Trial Overview The trial is testing three approaches to address prescription stimulant misuse among college students: a control group with no intervention, face-to-face counseling (F2F), and electronic screening and brief intervention (eSBI). It's designed to see how feasible and effective these methods are.

Participant Groups

Group I: eSBI Experimental Treatment 1 Intervention

After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.

Group II: F2F Experimental Treatment 1 Intervention

After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.

Group III: Control Placebo Group 1 Intervention

Students complete the assessments at each time point, but do not receive any intervention or informational material.

Who Is Running the Clinical Trial?

California State University, Long Beach

Lead Sponsor

Trials

7

Recruited

5,500+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+

Findings from Research

This study is evaluating the effectiveness of the Screening and Brief Intervention (SBI) approach for illicit drug use through a randomized controlled trial involving 700 participants in emergency departments, aiming to provide valuable insights into its efficacy.

The training of bicultural health educators (HEs) in motivational interviewing and their ongoing evaluation contributed to successful participant recruitment and skill mastery, highlighting the importance of well-prepared staff in delivering effective interventions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Randomized controlled trial to evaluate screening and brief intervention for drug-using multiethnic emergency and trauma department patients. Eisenberg, K., Woodruff, SI.[2021]

References

1. Netherlands pubmed.ncbi.nlm.nih.gov

A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. [2021]

2. England pubmed.ncbi.nlm.nih.gov

Detecting drug diversion in health-system data using machine learning and advanced analytics. [2022]

3. England pubmed.ncbi.nlm.nih.gov

Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication. [2015]

4. United States pubmed.ncbi.nlm.nih.gov

The Diversion of Prescription Opioid Analgesics. [2021]

5. United States pubmed.ncbi.nlm.nih.gov

Descriptive analysis of the legal ramifications of medication diversion by pharmacy employees. [2023]

6. England pubmed.ncbi.nlm.nih.gov

Testing the effects of brief intervention in primary care for problem drug use in a randomized controlled trial: rationale, design, and methods. [2021]

7. England pubmed.ncbi.nlm.nih.gov

Randomized controlled trial to evaluate screening and brief intervention for drug-using multiethnic emergency and trauma department patients. [2021]

8. England pubmed.ncbi.nlm.nih.gov

Effectiveness of brief interventions as part of the Screening, Brief Intervention and Referral to Treatment (SBIRT) model for reducing the nonmedical use of psychoactive substances: a systematic review. [2022]

9. United States pubmed.ncbi.nlm.nih.gov

Short-term Efficacy of a Brief Intervention to Reduce Drug Misuse and Increase Drug Treatment Utilization Among Adult Emergency Department Patients. [2018]

10. United States pubmed.ncbi.nlm.nih.gov

Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. [2022]